Publication | Open Access
Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain
285
Citations
41
References
2008
Year
Lapatinib is the first HER2-directed drug to be validated in a preclinical model for activity against brain metastases of breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1